Skip to main content
SpringerLink
Log in

Management of Eyelid Retraction in Active TED

  • Chapter
  • First Online:
Surgery in Thyroid Eye Disease

  • 376 Accesses

Abstract

Thyroid eye disease (TED) is an autoimmune disease that often leads to facial disfigurement. Graves’ Upper Eyelid Retraction (GUER) is one of the most common sign in TED, and has functional as well as cosmetic implications [1, 2]. Surgical correction remains the mainstay for the treatment of eyelid retraction, and shall be separately covered in Chap. 15. However, during the active phase of the disease, a temporary modality for correction is desirable.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Frueh BR, Musch DC, Garber FW. Lid retraction and levator aponeurosis defects in graves’ eye disease. Ophthalmic Surg. 1986;17:216–20.

    CAS  PubMed  Google Scholar 

  2. Weetman AP, Disease Grave’s Horm Res 1835–2002 ;2003(59Suppl1):114–118.

    Google Scholar 

  3. Träisk F, Tallstedt L. Thyroid associated ophthalmopathy: botulinum toxin a in the treatment of upper eyelid retraction--a pilot study. Acta Ophthalmol Scand. 2001;79:585–8.

    Article  Google Scholar 

  4. Erickson BP, Lee WW, Cohen J, et al. The role of neurotoxins in the periorbital and midfacial areas. Facial Plast Surg Clin North Am. 2015;23:243–55.

    Article  Google Scholar 

  5. Morgenstern KE, Evanchan J, Foster JA, et al. Botulinum toxin type a for dysthyroid upper eyelid retraction. Ophthalmic Plast Reconstr Surg. 2004;20:181–5.

    Google Scholar 

  6. Scott AB. Injection treatment of endocrine orbital myopathy. Doc Ophthalmol. 1984;58:141–5.

    Article  CAS  Google Scholar 

  7. Ebner R. Botulinum toxin type a in upper lid retraction of graves’ ophthalmopathy. J Clin Neuroophthalmol. 1993;13:258–61.

    CAS  PubMed  Google Scholar 

  8. Biglan AW. Control of eyelid retraction associated with graves’ disease with botulinum a toxin. Ophthalmic Surg. 1994;25:186–8.

    CAS  PubMed  Google Scholar 

  9. Ozkan SB, Can D, Söylev MF, et al. Chemodenervation in treatment of upper eyelid retraction. Ophthalmologica. 1997;211:387–90.

    Article  CAS  Google Scholar 

  10. Uddin JM, Davies PD. Treatment of upper eyelid retraction associated with thyroid eye disease with subconjunctival botulinum toxin injection. Ophthalmology. 2002;109:1183–7.

    Article  Google Scholar 

  11. Shih MJ, Liao SL, Lu HY. A single transcutaneous injection with Botox for dysthyroid lid retraction. Eye. 2004;18:466–9.

    Article  CAS  Google Scholar 

  12. Costa PG, Saraiva FP, Pereira IC, et al. Comparative study of Botox injection treatment for upper eyelid retraction with 6-month follow-up in patients with thyroid eye disease in the congestive or fibrotic stage. Eye. 2009;23:767–73.

    Article  CAS  Google Scholar 

  13. Salour H, Bagheri B, Aletaha M, et al. Transcutaneous dysport injection for treatment of upper eyelid retraction associated with thyroid eye disease. Orbit. 2010;29:114–8.

    Article  Google Scholar 

  14. Grisolia ABD, Couso RC, Matayoshi S, Douglas RS, Briceño CA. Non-surgical treatment for eyelid retraction in thyroid eye disease (TED). Br J Ophthalmol. 2017 Aug;9

    Google Scholar 

  15. Nguyen AT, Ahmad J, Fagien S, et al. Cosmetic medicine: facial resurfacing and injectables. Plast Reconstr Surg. 2012;129:142e–53.

    Article  Google Scholar 

  16. Goldberg RA, Fiaschetti D. Filling the periorbital hollows with hyaluronic acid gel: initial experience with 244 injections. Ophthalmic Plast Reconstr Surg. 2006;22:335–41. Discussion 341–333

    Google Scholar 

  17. Mancini R, Khadavi NM, Goldberg RA. Nonsurgical management of upper eyelid margin asymmetry using hyaluronic acid gel filler. Ophthalmic Plast Reconstr Surg. 2011;27:1–3.

    Google Scholar 

  18. Malhotra R. Deep orbital sub-Q restylane (nonanimal stabilized hyaluronic acid) for orbital volume enhancement in sighted and anophthalmic orbits. Arch Ophthalmol. 2007;125:1623–9.

    Article  Google Scholar 

  19. Mancini R, Taban M, Lowinger A, et al. Use of hyaluronic acid gel in the management of paralytic lagophthalmos: the hyaluronic acid gel "gold weight". Ophthalmic Plast Reconstr Surg. 2009;25:23–6.

    Google Scholar 

  20. Kwong Q, Malhotra R, Morley AM, et al. Use of dermal filler to improve exposure keratopathy in a patient with restrictive dermopathy. Orbit. 2013;32:70–2.

    Article  Google Scholar 

  21. Taban M, Mancini R, Nakra T, et al. Nonsurgical management of congenital eyelid malpositions using hyaluronic acid gel. Ophthalmic Plast Reconstr Surg. 2009;25:259–63.

    Google Scholar 

  22. Kohn JC, Rootman DB, Liu W, et al. Hyaluronic acid gel injection for upper eyelid retraction in thyroid eye disease: functional and dynamic high-resolution ultrasound evaluation. Ophthalmic Plast Reconstr Surg. 2014;30:400–4.

    Google Scholar 

  23. Romero R, Sanchez-Orgaz M, Granados M, et al. Use of hyaluronic acid gel in the management of cicatricial ectropion: results and complications. Orbit. 2013;32:362–5.

    Article  Google Scholar 

  24. Peckinpaugh JL, Reddy HS, Tower RN. Large particle hyaluronic acid gel for the treatment of lower eyelid retraction associated with radiation-induced lipoatrophy. Ophthalmic Plast Reconstr Surg. 2010;26:377–9.

    Google Scholar 

  25. Zamani M, Thyagarajan S, Olver JM. Functional use of hyaluronic acid gel in lower eyelid retraction. Arch Ophthalmol. 2008;126:1157–9.

    Article  Google Scholar 

  26. Goldberg RA, Lee S, Jayasundera T, et al. Treatment of lower eyelid retraction by expansion of the lower eyelid with hyaluronic acid gel. Ophthalmic Plast Reconstr Surg. 2007;23:343–8.

    Google Scholar 

  27. Schanz S, Schippert W, Ulmer A, et al. Arterial embolization caused by injection of hyaluronic acid (Restylane). Br J Dermatol. 2002;146:928–9.

    Article  CAS  Google Scholar 

  28. Salvi M, Campi I. Medical treatment of graves’ Orbitopathy. Horm Metab Res. 2015;47:779–88.

    Article  CAS  Google Scholar 

  29. Goldberg RA. Orbital steroid injections. Br J Ophthalmol. 2004;88:1359–60.

    Article  CAS  Google Scholar 

  30. Ebner R, Devoto MH, Weil D, et al. Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone. Br J Ophthalmol. 2004;88:1380–6.

    Article  CAS  Google Scholar 

  31. Chee E, Chee SP. Subconjunctival injection of triamcinolone in the treatment of lid retraction of patients with thyroid eye disease: a case series. Eye. 2008;22:311–5.

    Article  CAS  Google Scholar 

  32. Xu D, Liu Y, Xu H, et al. Repeated triamcinolone acetonide injection in the treatment of upper-lid retraction in patients with thyroid-associated ophthalmopathy. Can J Ophthalmol. 2012;47:34–41.

    Article  CAS  Google Scholar 

  33. Lee SJ, Rim TH, Jang SY, et al. Treatment of upper eyelid retraction related to thyroid- associated ophthalmopathy using subconjunctival triamcinolone injections. Graefes Arch Clin Exp Ophthalmol. 2013;251:261–70.

    Article  CAS  Google Scholar 

  34. Lee JM, Lee H, Park M, et al. Subconjunctival injection of triamcinolone for the treatment of upper lid retraction associated with thyroid eye disease. J Craniofac Surg. 2012;23:1755–8.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ophthalmic Plastic Surgery Service, LV Prasad Eye Institute, Hyderabad, India

    Milind N. Naik

Authors
  1. Milind N. Naik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Milind N. Naik .

Editor information

Editors and Affiliations

  1. Ophthalmic Plastic Surgery Service, LV Prasad Eye Institute, Bhubaneswar, India

    Suryasnata Rath

  2. Ophthalmic Plastic Surgery Service, LV Prasad Eye Institute, Hyderabad, India

    Milind N. Naik

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Naik, M.N. (2020). Management of Eyelid Retraction in Active TED. In: Rath, S., Naik, M. (eds) Surgery in Thyroid Eye Disease. Springer, Singapore. https://doi.org/10.1007/978-981-32-9220-8_5

Download citation

  • DOI: https://doi.org/10.1007/978-981-32-9220-8_5

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-32-9219-2

  • Online ISBN: 978-981-32-9220-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation